Cabenuva is a long acting HIV treatment that combines two medicines, cabotegravir and rilpivirine, for certain adults and adolescents living with HIV. Unlike daily oral antiretroviral therapy, Cabenuva is administered as injections at scheduled intervals. It is intended for people whose HIV is already well controlled on an antiretroviral regimen and who meet specific medical criteria. Understanding how Cabenuva works, who may be eligible, how it is administered, and what precautions are involved can help patients discuss treatment choices with qualified healthcare professionals.
Cabenuva is a long acting HIV treatment that combines two medicines, cabotegravir and rilpivirine, for certain adults and adolescents living with HIV. Unlike daily oral antiretroviral therapy, Cabenuva is administered as injections at scheduled intervals. It is intended for people whose HIV is already well controlled on an antiretroviral regimen and who meet specific medical criteria. Understanding how Cabenuva works, who may be eligible, how it is administered, and what precautions are involved can help patients discuss treatment choices with qualified healthcare professionals. This article provides general educational information only and is not intended as medical advice, diagnosis, treatment, sales, or service.
Cabenuva contains two antiretroviral medicines that target HIV at different stages of the viral replication process. Cabotegravir is an integrase inhibitor, while rilpivirine is a nonnucleoside reverse transcriptase inhibitor. Together, they help maintain suppression of HIV when used appropriately.
Cabenuva may be considered for people who have achieved sustained viral suppression with another antiretroviral treatment. Before switching, healthcare professionals generally evaluate the person's treatment history, current HIV viral load, possible drug resistance, medications, and other health considerations.
Important considerations include:
Cabenuva is administered by a healthcare professional as intramuscular injections.
It is generally used after HIV viral suppression has been established.
Healthcare professionals assess whether the patient's previous treatment history is compatible with the medicines.
Drug interactions and previous resistance to cabotegravir or rilpivirine may affect whether Cabenuva is appropriate.
Regular appointments are important because maintaining the recommended injection schedule supports continued treatment effectiveness.
Cabenuva follows a scheduled injection regimen rather than requiring daily tablets. Depending on the prescribed treatment plan, injections are generally given at regular intervals. Healthcare professionals may discuss an oral lead in or other transition approaches when appropriate.
Injection site reactions are among the more common effects associated with Cabenuva. These can include pain, tenderness, swelling, redness, or a small lump where the injection was given. Such reactions often improve over time, although experiences can vary.
Other considerations may include:
Headache, fever, fatigue, muscle pain, or nausea can occur in some people.
Patients should inform their healthcare professional about all prescription medicines, over the counter medicines, and supplements they use.
Missing scheduled injections can affect treatment management and may require an alternative medication plan.
Healthcare professionals may monitor HIV viral load and other relevant health measures during treatment.
Cabenuva should be used according to the prescribed schedule and should not be stopped or changed without medical guidance.
Cabenuva is not a cure for HIV. Like other effective antiretroviral treatments, its purpose is to suppress HIV and help maintain long term control of the infection. People receiving treatment should continue appropriate medical follow up and discuss any concerns about side effects or missed appointments with their healthcare
Cabenuva provides a long acting treatment option for certain people with HIV who meet specific eligibility requirements. Its combination of cabotegravir and rilpivirine allows treatment to be delivered through scheduled injections rather than relying solely on daily oral medication. Understanding eligibility, injection schedules, possible side effects, medication interactions, and the importance of ongoing monitoring can help individuals have informed discussions with their healthcare professionals. Medical decisions should always be based on individual circumstances and professional guidance.